United States - English - NLM (National Library of Medicine)

bristol-myers squibb company - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - glucophage is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. glucophage xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glucophage and glucophage xr are contraindicated in patients with: - severe renal impairment (egfr below 30 ml/min/1.73 m2 ) [see warnings and precautions (5.1)]. - hypersensitivity to metformin. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. risk summary limited data with glucophage/glucophage xr in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. published studies with metformin use during pregnancy have not reported a clear association with metformin and major birth defect or miscarriage risk [see data ]. there are risks to the mother and fetus associated with poorly controlled diabetes mellit

Israel - English - Ministry of Health

abic ltd. - metformin hydrochloride - caplets - metformin hydrochloride 850 mg - metformin - metformin - glucophage is indicated in diet-failed, non-insulin dependent diabetic patients, especially if overweight, either alone as initial therapy or in combination with a sulfonylyrea. occasionally, as adjuvant therapy in insulin-dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck (pty) ltd - tablet - see ingredients - each tablet contains metformin hydrochloride 850 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merck (pty) ltd - tablet - see ingredients - each tablet contains metformin hydrochloride 1000,0 mg

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - glucophage is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. glucophage xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glucophage and glucophage xr are contraindicated in patients with: - severe renal impairment (egfr below 30 ml/min/1.73 m2) [see warnings and precautions ( 5.1)]. - hypersensitivity to metformin. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. risk summary limited data with glucophage/glucophage xr in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. published studies with metformin use during pregnancy have not reported a clear association with metformin and major birth defect or miscarriage risk [see data ]. there are risks to the mother and fetus associated with poorly controlled diabetes mell

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; povidone - metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulphonylurea failure, either alone or in combination with a sulphonylurea or as adjuvant therapy in insulin-dependent diabetes.

Israel - English - Ministry of Health

abic ltd. - metformin hydrochloride - caplets - metformin hydrochloride 850 mg - metformin - treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.• in adults, glucophage may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.• in children from 10 years of age and adolescents, glucophage may be used as monotherapy or in combination with insulin.a reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - metformin hydrochloride - tablet, extended release - 500 mg - metformin hydrochloride 500 mg

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - metformin hydrochloride (eqv 780mg metformin base) - tablet, extended release - 1000 mg - metformin hydrochloride (eqv 780mg metformin base) 1000 mg